CA2234817A1 - Wet granulation formulation of a growth hormone secretagogue - Google Patents
Wet granulation formulation of a growth hormone secretagogue Download PDFInfo
- Publication number
- CA2234817A1 CA2234817A1 CA 2234817 CA2234817A CA2234817A1 CA 2234817 A1 CA2234817 A1 CA 2234817A1 CA 2234817 CA2234817 CA 2234817 CA 2234817 A CA2234817 A CA 2234817A CA 2234817 A1 CA2234817 A1 CA 2234817A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- active ingredient
- diluent
- carbonyl
- piperdin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US589795P | 1995-10-27 | 1995-10-27 | |
US590195P | 1995-10-27 | 1995-10-27 | |
US60/005,901 | 1995-10-27 | ||
US60/005,897 | 1995-10-27 | ||
GBGB9603238.8A GB9603238D0 (en) | 1996-02-16 | 1996-02-16 | Wet granulation formulation of a growth hormone secretagogue |
GB9603238.8 | 1996-02-16 | ||
GB9603834.4 | 1996-02-23 | ||
GBGB9603834.4A GB9603834D0 (en) | 1996-02-23 | 1996-02-23 | Amorphous form of a growth hormone secretagogue |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2234817A1 true CA2234817A1 (en) | 1997-05-01 |
Family
ID=27451404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2234817 Abandoned CA2234817A1 (en) | 1995-10-27 | 1996-10-23 | Wet granulation formulation of a growth hormone secretagogue |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0857020A4 (ja) |
JP (1) | JPH11513989A (ja) |
AU (1) | AU7522896A (ja) |
CA (1) | CA2234817A1 (ja) |
WO (1) | WO1997015191A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100699404B1 (ko) | 1999-02-18 | 2007-03-23 | 가켄 세야쿠 가부시키가이샤 | 성장 호르몬 분비촉진제로서의 신규 아미드 유도체 |
JP4644402B2 (ja) * | 1999-07-26 | 2011-03-02 | ベイラー カレッジ オブ メディスン | 超高活性ブタ成長ホルモン放出ホルモン類似体 |
MXPA02004650A (es) * | 1999-11-12 | 2002-09-02 | Scherer Technologies Inc R P | Granulos amortiguadores de celulosa microcristalina. |
AU2001276608A1 (en) * | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
EP1377276B1 (en) * | 2001-04-10 | 2011-10-05 | Sun Pharma Advanced Research Company Limited | Timed pulse release composition |
SI1596870T2 (sl) | 2002-12-20 | 2011-07-29 | Hoffmann La Roche | Formulacija z visokim odmerkom ibandronata |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
UY29527A1 (es) * | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
AU2008241532A1 (en) | 2007-02-09 | 2008-10-30 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
JP5637624B2 (ja) * | 2009-02-12 | 2014-12-10 | 富士化学工業株式会社 | 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物 |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
WO2024096892A1 (en) | 2022-11-03 | 2024-05-10 | Lumos Pharma, Inc. | Compactable oral formulations of ibutamoren |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536716A (en) * | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
EP0813414A4 (en) * | 1993-10-19 | 1999-07-21 | Merck & Co Inc | COMBINATION OF BISPHOSPHONATES AND THE GROWTH HORMONE SECRETION PROMOTING SUBSTANCES |
-
1996
- 1996-10-23 EP EP96937761A patent/EP0857020A4/en not_active Withdrawn
- 1996-10-23 JP JP9516841A patent/JPH11513989A/ja active Pending
- 1996-10-23 AU AU75228/96A patent/AU7522896A/en not_active Abandoned
- 1996-10-23 WO PCT/US1996/017196 patent/WO1997015191A1/en not_active Application Discontinuation
- 1996-10-23 CA CA 2234817 patent/CA2234817A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH11513989A (ja) | 1999-11-30 |
AU7522896A (en) | 1997-05-15 |
EP0857020A1 (en) | 1998-08-12 |
EP0857020A4 (en) | 1999-01-07 |
WO1997015191A1 (en) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6123964A (en) | Wet granulation formulation of a growth hormone secretagogue | |
US5767124A (en) | Polymorphic forms of a growth hormone secretagogue | |
US5783582A (en) | Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone | |
US5804578A (en) | Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone | |
DE60112753T2 (de) | Verbindungen zur stimulation der sekretion von wachstumshormonen | |
CA2234817A1 (en) | Wet granulation formulation of a growth hormone secretagogue | |
WO1998010653A1 (en) | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone | |
US5877182A (en) | Piperidines promote release of growth hormone | |
JP2000514840A (ja) | 成長ホルモン分泌促進物質としての置換ジペプチドの酒石酸塩 | |
JPH10506914A (ja) | 4−複素環式ピペリジンは成長ホルモンの放出を促進する | |
WO1997036873A1 (en) | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone | |
JP2509147B2 (ja) | 成長ホルモンの放出を亢進させるスピロピペリジン及び同族体 | |
US5880125A (en) | 4-spiroindoline piperidines promote release of growth hormone | |
US5965565A (en) | Piperidines promote release of growth hormone | |
JPS6318600B2 (ja) | ||
WO1998025897A1 (en) | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone | |
KR20020015987A (ko) | 성장 호르몬 분비촉진제로서의 신규 아미드 유도체 | |
GB2297972A (en) | Camphor compounds promote release of growth hormone | |
EP1200432B1 (en) | Amido spiropiperidines promote the release of growth hormone | |
AU707946B2 (en) | Polymorphic forms of a growth hormone secretagogue | |
CA2164296C (en) | Heterocyclic chemistry | |
MXPA98003351A (en) | ot. POLYMORPHIC FORMS OF A GROWTH HORMONE SECRETAGOGUE | |
CZ20003152A3 (cs) | Soli N-methyi-N-((lR)-l-(N-methyl-N-((lR)-l- (methylkarbamoyl)-2-fenylethyl)karbamoyl)-2 (2-naftyl)ethyl)amidu (2E)-5-amino-5-methylhex- 2-enové kyseliny | |
BRPI9611229B1 (pt) | Polymorphic form of the compound of N- [1 (R) - [(1,2-dihydro-1-methanesulfonyl-spiro [3 H -indol-3,4'-piperdin] -1'-yl) carbonyl] -2- - (phenylmethyl oxy) ethyl] -2-amino-2-methylpropanamide and pharmaceutical composition | |
MXPA01004290A (en) | Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |